[[adverse effect|Adverse event]]s are more common among women taking flibanserin. The majority of adverse events were mild to moderate. The most commonly reported adverse events included [[dizziness]], [[nausea]], [[Fatigue (medical)|feeling tired]], [[somnolence|sleepiness]], and [[insomnia|trouble sleeping]].<ref name=UCM215437>{{cite web |url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM215437.pdf |format=PDF |title=Proposed Indication: Flibanserin is indicated for the treatment of hypoactive sexual desire disorder in premenopausal women |date=May 20, 2010 |accessdate=June 16, 2010}}</ref>

 


 
Drinking alcohol while on flibanserin may result in severely [[hypotension|low blood pressure]] (low blood pressure that produced symptoms occurred after only 2 glasses of wine occurred in 17%).<ref>{{cite web|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526REMS.pdf|page=42|title=FDA Risk Evaluation and Mitigation Strategy of Addyi}}</ref>

 

